Navigation Links
PPTA Opposes Tax on Blood Clotting Factor
Date:6/15/2011

ANNAPOLIS, Md., June 15, 2011 /PRNewswire/ -- PPTA opposes New Jersey Assembly Bill 2003 passed by the New Jersey Assembly Appropriations Committee on June 13 that imposes a new tax on therapies used to treat bleeding disorders like hemophilia.

The bill creates The Bleeding Disorders Treatment Fund by taxing the manufacturers of blood clotting factor in the form of a 6 percent rebate. PPTA opposes any policy that would impose a tax on the sale of lifesaving therapies. PPTA calls on the pharmaceutical industry at large to keep a close watch on this bill, which is a slippery slope towards taxing other medicines.

Blood clotting factor is a highly complex, lifesaving therapy that treats rare, genetic bleeding disorders such as hemophilia. This tax would be the first of its kind in the country where a state government would tax one type of business that provides a service for patients and subsequently gives the tax proceeds to other businesses that provide services to those same patients.

"This 'rebate' is nothing more than the tax on clotting factor sales that was proposed and failed in the last session," said Julie Birkofer, senior vice president, North America, PPTA. "It sets a dangerous precedent that could have a negative impact on patient access to clotting factor."

Plasma protein therapies, which include plasma-derived therapies and recombinant blood clotting factors (a biotechnology product), are biological products that are not interchangeable, and no generics or substitutions exist. These unique therapies are used every day to treat people with bleeding disorders such as hemophilia, which causes painful internal bleeding and debilitating joint damage; primary immunodeficiency diseases, which render the body defenseless from even the most common infections, often leading to pneumonia and other serious illnesses; and alpha-1 antitrypsin deficiency, also known as genetic chronic obstructive pulmonary disease (COPD). Additionally, al
'/>"/>

SOURCE Plasma Protein Therapeutics Association (PPTA)
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. To Reach, Perchance to Kill the Cancer: A Soliloquy From Epeius Nanotechnologies Opposes That Sea of Troubles
2. MDMA Board Unanimously Opposes Medical Device Tax
3. Regulus Therapeutics and Collaborators from NYU Langone Medical Center Publish New Data Demonstrating Clearance of Cholesterol from Bloodstream and Reduction of Atherosclerotic Plaques through Inhibition of microRNA-33
4. MD Anderson and Biocept Scientists to Present Poster at ASCO on Disseminated Tumor Cells (DTCs) in Bone Marrow and Circulating Tumor Cells (CTCs) in Blood in Early Stage Breast Cancer Patients
5. FDA: Treatment With Angiotensin Receptor Blockers for High Blood Pressure Does Not Increase Risk of Cancer
6. EMIT Corporation Receives FDA 510(k) Clearance for HypothermX™ Blood and Fluid Warmer.
7. OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test and Clinical Assessment
8. The Childrens Hospital of Philadelphia Partners with Vascular Magnetics, Inc. to Pursue Commercial Potential of Blood Vessel Research
9. New Device to Support Blood Circulation for Heart Patients Shows Improved Outcomes Compared to Current Treatment
10. HERCULES Trial Demonstrates Significant Reduction in Systolic Blood Pressure While Revealing Marker in Hypertensive Patients Does Not Predict Outcomes of Renal Artery Stenting
11. Resource Now Available to Help Clinicians Reduce Risk of Blood Exposure from Short Peripheral IV Catheter Insertion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 2013 /PRNewswire-iReach/ -- Today at American Society for ... Ginocchio discussed Specific Technologies blood culture ... of microorganisms producing bloodstream infection. Dr. Ginocchio is ... Division of Infectious Disease Diagnostics at North Shore-LIJ ... health system. (Photo: http://photos.prnewswire.com/prnh/20130520/CG16829 ) ...
(Date:5/20/2013)... Calif. , May 20, 2013 /PRNewswire-iReach/ -- ... of the first study demonstrating detection of pathogenic ... Yersinia pestis and Bacillus anthracis ... and Prevention,s list of potential bio-threats. This seminal ... and Technology Laboratory, Salisbury ...
(Date:5/20/2013)... , May 20, 2013  Hill-Rom Holdings, Inc. (NYSE: ... a management presentation at the 38 th Annual ... on May 30, 2013, at 1:30 p.m. ... You are invited to listen to the live ... or access it directly at http://www.media-server.com/m/p/f7bj3q84 . A ...
Breaking Medicine Technology:Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 3Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria 2
... 7, 2011 Rochester Medical Corporation (NASDAQ: ... the previously announced purchase of Laprolan B.V., the former ... BioSciences N.V. Under the terms of the purchase agreement ...  For more information regarding this transaction please refer to ...
... April 7, 2011 Ascension Orthopedics, Inc., a world ... the TITAN Modular Total Shoulder.  The surgeries were performed ... Baltimore, MD.     "I have been ... of years in my practice. Now that Ascension has ...
Cached Medicine Technology:Ascension Orthopedics Announces TITAN™ Modular Shoulder Implantations at Union Memorial Hospital 2
(Date:5/20/2013)... DC (PRWEB) May 20, 2013 Medicare ... are overwhelmingly satisfied, citing lower costs, convenient access to ... from Hart Research Associates released today by the Pharmaceutical ... D seniors (9.5 million) are currently enrolled in plans ... pharmacy choices, and overall value of plans with preferred ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 A new ... by MedEx Direct, the creators of the MedEx Pack ... the Benefits of Pharmacy Home Delivery, in order to provide ... their prescriptions are handled. Clyde Furuta, MedEx Direct owner ... home delivery is that with a product like the MedEx ...
(Date:5/20/2013)... improved health care and significant reductions in drug costs ... between physicians and drug company representatives who promote the ... This system, which has been in place for decades, ... to date on new medications, and always provided generous ... the newest drugs, as well as other supplies and ...
(Date:5/20/2013)... T.E.N. announced today that it would ... Security Executive® Northeast Awards now through Friday, July ... Security Executive® of the Year and ISE® People’s ... a positive impact on their organizations through risk ... security; and the ISE® Project of the Year, ...
(Date:5/20/2013)... Geneva, Switzerland (PRWEB) May 20, 2013 ... discovery for lead identification and cell line development for ... that the Company’s co-founder will present data on the ... Development & Engineering Conference, May 20 - 23 ... La Jolla, California. Selexis’ co-founder and scientific advisory board ...
Breaking Medicine News(10 mins):Health News:Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2Health News:Benefits of Pharmacy Home Delivery Report Published by MedEx Direct 2Health News:Breakup of physician, drug company relationship could improve health care, cut cost 2Health News:Breakup of physician, drug company relationship could improve health care, cut cost 3Health News:T.E.N. Announces Call for Nominations for the ISE® Northeast Awards 2013 2Health News:T.E.N. Announces Call for Nominations for the ISE® Northeast Awards 2013 3Health News:Selexis SA to Present Technology Platform Data at Cell Line Development & Engineering 2Health News:Selexis SA to Present Technology Platform Data at Cell Line Development & Engineering 3
... Children, WASHINGTON, Oct. 3 Campaign for ... veto of the,Children,s Health Insurance Program Reauthorization bill ... nation,s broken health care systems. The bill,the president ... for 6.6 million children and provide coverage to ...
... Information,Systems, Inc., (Nasdaq: MEDW ) announced that ... the company regarding the company,s,non-compliance with Nadsaq Marketplace ... company,s audit committee. This issue arose,due to the ... an audit,committee member. On October 2, 2007, ...
... say , WEDNESDAY, Oct. 3 (HealthDay News) -- Identifying ... the best chemotherapy for patients, U.S. research suggests. , ... most likely to respond to standard first-line therapy and ... a second-line therapy, based on gene expression profiling," lead ...
... outcomes for high-risk patients , , WEDNESDAY, Oct. 3 (HealthDay ... the bare-metal kind for high-risk patients with blocked coronary ... of restenosis -- having the artery become blocked again ... following two years for those getting drug-coated stents, 7.4 ...
... Oct. 3 Abaxis, Inc.,(Nasdaq: ABAX ), ... systems, announced today the launch of the Kidney,Check ... Piccolo xpress(TM) point of,care analyzer. The new ... and,radiology centers in the United States to determine ...
... Nowhere are the,consequences of premature birth more evident than ... the next week, 563 babies,will be born too soon ... watch their babies be admitted into a NICU. Having ... the most frightening and overwhelming,experiences a parent faces. ...
Cached Medicine News:Health News:Mediware Information Systems, Inc. Receives Notice from the Nasdaq Stock Market 2Health News:Gene Tests Match Up Lung Tumors, Best Treatment 2Health News:Study Finds Benefits With Drug-Coated Stents 2Health News:Study Finds Benefits With Drug-Coated Stents 3Health News:Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers 2Health News:Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers 3Health News:March of Dimes NICU Family Support(R) Programs Give Florida Families Comfort and Information During a Crisis 2
... The innovative E.coli ... Pro-Lab offers definitive identification ... the use of a ... the possibility of cross-reactions ...
A single tube that performs two rapid tests for E. coli from culture. ColiScreen™ combines both the indole test with the glucuronidase test to increase the specificity....
The Oxoid Legionella Latex Test is a latex agglutination test for the identification of predominant Legionella species grown on plate media from patients with suspected Legionellosis or from environm...
Inquire...
Medicine Products: